Back

CSL112 (apolipoprotein A-I [human]) reduces the elevation in neutrophil-lymphocyte ratio (NLR) induced by acute myocardial infarction

28 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Preclinical and clinical laboratory markers in chronic coronary syndromes Pharmacotherapy ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Bronwyn Kingwell

CSL Ltd, Melbourne (Australia)

6 More presentations in this session

Presentation thumbnail
Soluble urokinase Plasminogen Activator Receptor (suPAR) is associated with educational attainment in patients with coronary artery disease
Mr D. Fueller (Brandenburg an der Havel, DE)
Abstract Slides Video
Presentation thumbnail
Fibroblast growth factor 23 is a strong independent marker of poor outcome after an acute coronary syndrome
Doctor A. Kallmeyer (Madrid, ES)
Abstract Slides Video
Presentation thumbnail
Acute exposure to PM2.5 promotes arterial stiffening by down-regulating serine and trans-4-hydroxyproline dependent pathways - results from an Asutralian cohort metabolomic study
Doctor S. Fathieh (London, GB)
Abstract Slides Video
Presentation thumbnail
Formation of denser plasma fibrin clots is associated with coronary artery ectasias and aneurysms - preliminary results from the CARE-ANEURYSM study
Doctor J. Chmiel (Krakow, PL)
Abstract Slides Video
Presentation thumbnail
Serum levels of the endoplasmic-reticulum-stress chaperone GRP78 are associated with inflammation, identify patients with coronary artery disease and predict mortality
Doctor M. Al Zaidi (Bonn, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Preclinical and clinical laboratory markers in chronic coronary syndromes

The Event

Event poster

ESC Congress 2023

28 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
ApoA-I Infusions and Burden of Ischemic Events after Acute Myocardial Infarction
thumbnail
Congress Session
Nature Medicine: 2025 highlights
thumbnail
Congress Session
Novel pharmacological approaches in acute coronary syndromes

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources